Skip to main content

Table 5 Over view of relevant literature in the treatment of Crowe IV dysplasia combined with subtrochanteric femoral shortening osteotomy

From: Mid-term results of total hip arthroplasty with modified trochanteric osteotomy in Crowe type IV developmental dysplasia of the hip

 

Patient (Hips)

DDH type

Osteotomy type

Follow up duration (y)

Pre LLD (mm)

Post LLD (mm)

Leg lengthening (mm)

Nerve injury

Osteotomy site union (m)

Non-union

Revision

Dislocation

Intraoperative

fracture

Ozden et al. [4]

35 patients

45 hips

Crowe IV

Step-cut

10 (range, 7–14)

33 ± 25 (range, 0–75)

10 ± 6 (range, 0–25)

37 ± 14 (range, 21–47)

1

3.8 ± 0.7 (range 3–6)

3

4 stem

1 acetabular component

2 closed reduction

2 performed surgery

5

Kiliçoğlu et al. [5]

16 patients

20 hips

Crowe IV

Modified oblique femoral shortening

6.8 (range, 3.7–10.3)

45 ± 10 (range, 30–65)

10 (range, 0–30)

35 ± 17 (range, 0–58)

0

4 (range, 3–6)

1

1 stem

1 acetabular component

2 closed reduction

1 performed surgery

3

Li et al. [6]

18patients

22 hips

Crowe IV

Double chevron

6.5 (range, 5–10)

45 (range, 30–62

15 (range, 0–24)

38 (range, 25–60)

0

3 to 6 months

0

0

0

0

Zhu et al. [7]

20 patients

21 hips

Crowe IV

Transverse

3.3 (range, 2–5)

47 ± 11(range, 20 -70)

12 ± 4 (range, 0–20)

38 ± 9 (range, 30–55)

2

5 (range, 3–9)

1

1 stem

1 closed reduction

0

Charity et al. [8]

15 patients

18 hips

Crowe IV

Shortening derotational

9.5 (range, 4.3–14)

No details

No details

30 (range, 10–40)

1

No details

1

3 acetabular component

0

0

Yalcin et al. [21]

31 patients

44 hips

Crowe IV

Transverse

5.3 (range, 2–8

34 (range, 20–60)

22 (range, 10–32)

> 20, 6 patients

< 20, 25 patients

27 (range, 19–45)0

4 (range, 2.5–14)

5

1 acetabular component

2 closed reduction

0

Wang et al. [24]

49 patients 56 hips

Crowe Type-III or IV

Transverse

10 (range, 4.8–14.3)

42 (range, 21–65)

11 (range, 6–14)

27 (range, 19–45)

3

6 (range, 4–9)

1

1 acetabular component

2 closed reduction

1 performed surgery

4

Rollo et al. [26]

15 patients

17 hips

Crowe IV

Transversal and Z-shaped

7.3 (range, 5.3–11.1)

45 (range, 38–90)

12 (range, 9–16)

39 (range, 30–50)

2

2.9 (range, 2.3–3.5)

0

0

0

1

Ollivier et al. [27]

24 patients

28 hips

Crowe IV

Transverse and step-cut

10 (range, 0.8–14.5)

43 (range, 26–60

6 (range, 0–20)

40 (range, 20–80)

0

10 (range, 2–28)

0

3 stem

1 acetabular component

2 closed reduction

1 performed surgery

5

Yasgur et al. [28]

8 patients

9 hips

Crowe IV

Transverse

3.6 (range, 2–7)

50 (range, 30–70

15 (range, 5–30)

35 (range, 30–55)

0

5 (range, 3–9)

1

1 stem

1 closed reduction

0

Wang et al. [29]

62 patients

76 hips

Crowe IV

Transverse

10 (range, 6.6–13.2)

43 (range, 21–65)

10 (range, 6–17)

22 (range, 12–38)

2

6 (range, 4–8)

1

1 stem

1 acetabular component

3 closed reduction

4

Baz et al. [32]

15 patients

21 hips

Crowe IV

Transverse

4.9 (range, 3–8)

58.19 (47–72)

No details

31.95 (21–45)

1 permanent

No details

No details

3 stem

1 acetabular component

2 performed surgery

5

Present series

13 patients

13 hips

Crowe IV

Modified trochanteric

5.2 (range, 4.9–6.1)

53.4 (range, 42.1–68.5)

5.6 (range, 2.4–9.1)

47.4 (range, 33.6–67.2)

0

2.5 (range, 1.5–3.6)

0

0

1 closed reduction

0

  1. DDH developmental dysplasia of the hip, LLD leg length discrepancy